Patient Selection Measures 933 Patient Education/Shared Decision-Making Measures 933 4.2. Outcome Measures 933 4.2.1. Level of Attribution/Aggregation 933 4.2.2. Infrequently Occurring Complications 933 4.2.3. Death/Readmission 934 4.2.4. Patient Surveys 934 4.3. Structural Measures 934 5. Measures Included in This Set 934 Comprehensive Documentation of Indications for PCI 934 5.2. Appropriate Indication for Elective PCI 935 Assessment of Candidacy for Dual-Antiplatelet Therapy 935 Use of Embolic Protection Devices in the Treatment of Saphenous Vein Bypass Graft Disease 935 Documentation of Preprocedural Glomerular Filtration Rate and Contrast Dose Used During the Procedure 936 5.6. Radiation Dose Documentation 936 Postprocedural Optimal Medical Therapy Composite 936 5.8. Cardiac Rehabilitation Patient Referral 936 Regional or National PCI Registry Participation 937 Annual Operator and Hospital PCI Volume 937 Potential Measures Considered But Not Included in This Set 937 6.1. Process Measures 937 6.2. Outcome Measures 937 6.3. Structural Measures 938 7. Areas for Further Research 939 Documentation of Prescription of Drugs Versus Filling of Drug Prescriptions and Optimal Dosing of Drugs 939 7.2. Limitations of Current Data Systems for PCI 939 7.3. Shared Accountability 939 7.4. Patient Surveys 939 Staff 939 References 940 Key Words 941 Appendix A. 